Aleva Neurotherapeutics
Series D+Aleva Neurotherapeutics raised €11M in a Series D+ round in Oct 2017. The company is based in Lausanne, Switzerland. Investors in the round: Forrestal Capital. Data as of Nov 2026.
Amount raised
€11M
€11,069,482
Native amount
13,000,000 USD
Stage
Series D+
series d
Investors
1
Provenance & confidence
High confidenceAmount
13,000,000 USD
ECB-at-date → €11M · rate 1.1744 on 2017-10-02
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.